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Abstract 
We have recently identified a cytoplasmic protein, al-RBF,,, that specifically interacts with the conserved 3’-untranslated region of the al(I) 
collagen gene. The binding activity was decreased in extracts from dexamethasone treated cells, which correlates with the known accelerated turnover 
of the COLl Al RNA [MPlttS, A. and Penttinen, R.P.K. (1993) Biochem. J. 295, 691-6981. Now we report that a very similar protein is present in 
nuclear extracts of NIH 3T3, human fibroblast and HeLa cells, which suggests that determination of cytoplasmic mRNA stability is not the sole 
function of the al-RBF,, activity. The binding to the RNA probe can be inhibited by annealing a DNA oligonucleotide or using excess of cold specific 
competitors. In UV-cross linking assays the nuclear protein has the same molecular weight (67 kDa) as the cytoplasmic one and the RNA-bound 
peptides generated by CNBr or V8 protease cleavage from both the cytoplasmic and the nuclear protein were identical. This protein was the only 
one of several nuclear collagen mRNA 3’-UTR binding proteins that was present in both nuclear and cytoplasmic extracts. In fibroblasts heparin- 
resistant nuclear RNA binding proteins had molecular weights of 45, 67 (ccl-RBF,,), and 71 kDa. HeLa-cells contained an additional protein of 
51 kDa and several non-specific RNA-binding proteins. The binding activity is modified by changes in the redox state, which implicates that in the 
nucleus the binding affinities of al(I) collagen RNA-binding protein and AP-1, a redox sensitive nuclear factor, that is important in the transcription 
of al(I) collagen gene, can be regulated simultaneously to the same direction. 
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1. Introduction 
In addition to transcriptional regulation, the level of 
collagen synthesis is determined by changes in the 
mRNA half-life. The stability of al(I) collagen mRNA 
can be modified by treatment of cells with different cy- 
tokines or hormones, alteration in cell adhesion and ma- 
lignant transformation [l-3], but the regulatory mecha- 
nisms are poorly understood. In general, mRNA stabil- 
ity is controlled by an interplay of &s-acting RNA struc- 
tures and truns-acting cellular proteins that either protect 
the mRNA or facilitate its degradation. Nuclear events 
in RNA metabolism include splicing of intron sequences 
and polyadenylation at the 3’-end of the maturating 
mRNA. After transport to cytoplasm the mRNA is sub- 
jected to the control of its half-life as a protein-mRNA 
complex. Some of the putative mRNA stability deter- 
mining factors have been assigned to polyribosome par- 
ticles and others have been identified in soluble cyto- 
plasmic extracts [4,5]. Recently, these factors have also 
been found in the nucleus [6,7], suggesting that the same 
proteins might bind and protect nascent or newly proc- 
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- 
essed nuclear RNAs and cytoplasmic mRNA until its 
degradation. 
The 3’-UTR of the al(I) collagen mRNA contains two 
highly conserved domains around the alternate poly- 
adenylation sites [8]. We have characterised a cytoplas- 
mic RNA-binding protein, which we named al-RBF,,. 
This factor was shown to specifically interact with a 
short segment of the first conserved domain in the al(I) 
collagen mRNA [9]. The binding activity was markedly 
decreased in dexamethasone treated fibroblasts, which 
might be related to the well known finding that glucocor- 
ticoid hormones destabilize al(I) collagen mRNA. 
Moreover, transient transfection assays suggest hat the 
3-UTR is, indeed, needed for the decrease in al(I) colla- 
gen mRNA levels after dexamethasone treatment [9]. 
Thus, the al-RBF,, binding activity seems to correlate 
with al(I) collagen mRNA stability. 
The al (I) collagen gene has 5 1 short exons which indi- 
cates that the processing of the hnRNA to the corre- 
sponding mRNA is a complex process, during which the 
RNA should be protected against nucleases. This 
prompted us to study the nuclear proteins binding to the 
conserved parts of the al(I) collagen mRNA in order to 
find, whether al-RBF,, or some other proteins are in- 
volved in the stabilisation of the mRNA in nucleus and 
during its transport to cytoplasm. The suggestions, that 
al(I) collagen mRNA can, on some occasions, be de- 
graded already in the nucleus [lo], further addressed the 
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importance of this issue. In this paper, we describe that 
a RNA binding activity similar to cxl -RBF,, is also pres- 
ent in nuclear extracts along with several other RNA- 
binding proteins, that are not present in the cytoplasm. 
2. Materials and methods 
2.1. Cell lines and protein extracts 
Cytoplasmic and nuclear extracts from 3T3 cells, human fibroblasts 
and suspension cultured HeLa cells were prepared using three different 
methods [I 1,12,13]. The cells were first incubated on ice for lo-15 min 
in a hypotonic buffer, and then disrupted by either dounce homogenisa- 
tion [11,12] or passages through a 25gauge hypodermic needle [13]. The 
nuclei were then pelleted by centrifugation for 30 s at 10,000 rpm [ll], 
15 min at 4000 rpm [ 1121 or 30 s in a tabletop microfuge (14,000 rpm) 
[13] at +4”C. The supematant was further cleared by re-centrifugation 
for 20 min at +4”C in a microfuge either as such [13] or after addition 
of KC1 to 140 mM [12] and labelled as a cytoplasmic extract. The lysis 
of the cells and intactness of the nuclei was controlled by light micros- 
copy. The nuclear pellets were briefly washed with a low-salt buffer 
(0.02 M KCl) and extracted in 0.42 M I1 1.131 or 1.2 M KC1 1121. The 
extracts were stored in small aliquots in -76°C. In addition, RNA- 
binding activities were tested in cell extracts obtained by a IO min lysis 
by 0.1% Triton X-100 on ice and pelleting of the nuclei and the cytoskel- 
eton for 10 min at +4”C in a microfuge. 
2.2. Production of labelled RNA-probes 
Preparation of templates for in vitro RNA synthesis (Fig. 1) have 
been described [9], except the 0.15 SspI-Hind111 fragment of the 
COLlAl 3’-UTR, which was subcloned from pGEM 0.3 TaqI-Hind111 
fragment into pBluescript KS (Stratagene). The probes were generated 
using the procedure recommended by the supplier for T7 and Sp6 RNA 
polymerases (Pharmacia). 
2.3. RNA-protein binding assays 
Gel retardation assays were performed as described [9]. In short, 
225 x IO4 cpm of each probe was incubated with the 
protein extract at room temperature in the presence of 200 ng/pl E. coli 
tRNA and 2 mg/ml heparin. The reactions were digested with 100 U 
RNase T and the bound probe was resolved from free digestion prod- 
ucts with a native 4.5% PAGE at +4”C. In experiments designed for 
the mapping of the binding site in the RNA, DNA oligonucleotides 
were annealed to the probe before the binding reaction by denaturing 
the probe and oligonucleotide for 5 min at + 80°C and allowing the 
N-pro Collagenous C-pro 3’-UTR 
mixture to renature to room temperature. The antisense Tl’ ohgonucle- 
otide (5’- TGGTAAGGTTGAATGCACTTTTG) maps 23 nucleotides 
upstream from the first polyadenylation signal. The other antisense 
oligonucleotide T2’ (5-GGTCAAAGATAAAAACTAAGTTTGAG) 
maps 66 nucleotides upstream from the same polyadenylation signal. 
UV-cross-linking assays were performed as described [7,9] except hat 
heparin was omitted in some experiments. The cross-linked proteins 
were analysed by SDS-PAGE along with “C-labelled molecular weight 
standards (Amersham) and visualised by autoradiography ofdried gels. 
For the peptide mapping the cross-linked proteins were subjected for 
either 100 ,~@l V8 protease (Endoproteinase Glu-C, Boehringer 
Mannheim) for 3 h at + 37°C or for 5 mg CNBr (Fluka, dissolved at 
50 mg/ml in 70% formic acid) for 2 h at +22”C. CNBr cleaves the 
proteins at methionine residues and V8 protease (in the conditions used) 
at glutamic and aspartic acid residues. The digested samples were analy- 
sed by 12% SDS-PAGE in non-reducing conditions and autoradiogra- 
phy. 
3. Results and discussion 
The need to study the nuclear RNA-binding proteins 
that recognise the first conserved domain of the al(I) 
collagen 3’-UTR was prompted by the following reasons. 
Firstly, we suspected that the al(I) collagen mRNA 
might bind to protective proteins already in nucleus. 
Herget et al. [14] had also found in myoblasts a nuclear, 
single-stranded DNA binding protein that bound to ap- 
proximately the same sequence as recognised by the al- 
RBF,, in RNA [9]. Secondly, we found that like several 
other RNA-binding proteins, the al-RBF,, was regu- 
lated by changes in the redox-state of free SH-groups; the 
binding was abolished when protein extracts were chem- 
ically modified by N-ethylmaleimide that alkylates SH- 
groups [9]. This regulation is similar to that which con- 
trols transcription factor binding to the AP-1 site in 
many genes. We and others have shown the importance 
of an intronic AP-1 site for the transcription of the al(I) 
collagen gene [ 15,161. Thus, redox regulation in the nu- 
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Fig. 1. Schematic representation of the human pro-al(I) collagen gene and its 3’-UTR. Open boxes denote coding sequences and black line 3’-UTR 
and flanking sequences. Black vertical bars represent he two alternate polyadenylation signals. The fragments ubcloned into pGEM-1 (Promega) 
vectors and used for in vitro RNA synthesis are presented as arrows. These probes are referred in the subsequent Figures according to the restriction 
enzymes delineating them. 
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Fig. 2. Nuclear extracts contain RNA-binding protein binding to same 
site as al-RBF,,. (A) Formation of one complex is inhibited by Tl’ 
oligonucleotide annealed to the probe. Lane (1) RNase T digested 
0.15 kb SspI-Hind111 probe alone; (2) 0.3 kb TuqI-Hind111 (PAl) probe 
without oligonucleotides bound to 10 fig of 3T3 nuclear extract in the 
presence of E. coli tRNA and heparin, digested with RNase T; (3) PA1 
probe annealed (see section 2) to Tl’ ohgonucleotide mapping 2040 
nucleotides upstream from the polyadenylation site prior to the binding 
reaction; (4) PAI probe annealed to T2’ oligonucleotide prior to the 
binding reaction; (5) the 0.15 kb &$-Hind111 RNA probe bound to 
nuclear extract; (6) SspI-Hind111 probe annealed to Tl’ oligonucleotide 
prior to the binding reaction; (7) .SspI-Hind111 probe annealed to T2 
oligonucleotide prior to the binding reaction. In this experiment the 
extract was prepared as described in [13]. The gel was a 4.5% native 
polyacryleamide gel run in a Tris-glycine buffer at +4”C. (B) The 
oligonucleotide Tl’ inhibits RNA-cytoplasmic protein interaction. The 
0.15 kb SspI-Hind111 probe was denatured and allowed slowly to anneal 
with indicated oligonucleotides. Binding reactions were performed with 
10 pg of 3T3 cytoplasmic proteins. Lane (1) probe denatured and 
renatured without oligonucleotides; (2) probe annealed to oligonucleo- 
tide Tl’; (3) probe annealed to oligonucleotide T2’. 
cleus could have a simultaneous effect both on transcrip- 
tion factors of the al(I) collagen gene and on putative 
regulators of the half-life of its mRNA. Thirdly, some 
other nuclear RNA-binding proteins have been sug- 
gested to participate in the control of mRNA stability [6]. 
Furthermore, nuclear RNA-binding proteins are major 
candidates for the control over the usage of the two 
alternate polyadenylation sites. The resulting two 
mRNAs of 4.7 and 5.8 kb sizes have different stabilities 
and, e.g. respond in a different way to TGF-/I applica- 
tion [17]. 
We used the TaqI-Hind111 (PAl) fragment that covers 
the whole 3’-UTR of the 4.8 kb mRNA species and its 
5’ and its 3’-terminal halves restricted at the SspI site as 
templates for in vitro RNA probe synthesis (Fig. 1). Gel 
retardation assays were performed using nuclear and 
cytoplasmic extracts of 3T3 cells. Binding assays with 
nuclear proteins were carried out in the same assay 
buffer as with cytoplasmic extracts. 
Gel retardation experiments with the 0.3 kb PA1 RNA 
probe and nuclear extract resulted in a broad smear 
migrating approximately at the position of al-RBF,,- 
PA1 RNA complex (Fig. 2A, lane 2). Previously we 
showed by competition assays with unlabeled RNA- 
transcripts and DNA oligonucleotides that the binding 
site of al-RBF,, resides in the 3’-terminal end of the 
0.3 kb PA1 probe, ca. 2&40 nucleotides upstream from 
the triplicate AATAAA polyadenylation signal [9]. 
When Tl’ oligonucleotide was annealed to the PA1 
probe before the binding reaction, two retarded com- 
plexes were still seen, but some material of the original 
complexes was lost (Fig. 2A, lane 3). T2’ oligonucleotide 
had no effect on the formation of the complex migrating 
like the al-RBF,, activity (Fig. 2A, lane 4). The 3’-termi- 
nal fragment was also used as a template for the RNA- 
probe for binding experiments with nuclear and cyto- 
plasmic extracts. A single complex was formed between 
the SspI-Hind111 probe and nuclear extract (Fig. 2A, 
lane 5). The complex formation was prevented by an- 
nealing of the oligonucleotide Tl’ to the probe (Fig. 2A, 
lane 6) but not by annealing the oligonucleotide T2 
(Fig. 2A lane 7). The results were similar when cytoplas- 
mic extracts were used (Fig. 2B). When oligonucleotide 
Tl’ was annealed to the SspI-Hind111 probe prior to the 
binding reaction no complex formation was seen (Fig. 
2B, lane 2) whereas the T2’ oligonucleotide annealing 
the near vicinity of the Tl site did not prevent the binding 
of cytoplasmic proteins (Fig. 2B, lane 3) confirming the 
results obtained with the longer 0.3 kb PA1 probe [9]. 
Finally, in competition assays with nuclear extracts and 
the 3’ terminal SspI-Hind111 probe, the specific unlabeled 
transcript perturbed the interaction between the probe 
and nuclear extracts (Fig. 3A; lane 4) like in the reactions 
with the cytoplasmic protein and RNA-probe [9]. We 
thus conclude, that both nuclear and cytoplasmic ex- 
tracts contain a protein that binds to the same site in the 
al(I) collagen 3’-UTR RNA. Besides the al-RBF,, 
which binds to the 3’-terminal SspI-Hind111 fragment, 
the full-length 0.3 kb PA1 probe bound other nuclear 
proteins (compare Fig. 2A, lanes 2 and 3 to lanes 5 and 
6) indicating that additional proteins might interact with 
the 5’ terminal part of the PA1 probe. 
The approximate sizes of the proteins participating in 
the complexes were determined by UV cross-linking. In 
this method the binding reactions are irradiated with 
UV-light, which results in covalent attachment of probe 




Fig. 3. (A) Competition experiment with the 3T3 nuclear extract and 
the 0.15 SspI-Hind111 probe. Unlabeled RNA-probes (all in approxi- 
mately 120x excess over the labelled probe) were allowed to bind nu- 
clear proteins 10 min prior to addition of the labelled probe. Lane (1) 
probe alone; (2) no competitors; (3) excess of antisense (AS) RNA; (4) 
excess of unlabeled sense SspI-Hind111 RNA. (B) UV cross-linking of 
PA1 probe and 3T3 extracts. Cross-linking of 10’ cpm of probe and 
20 pug of cytoplasmic (lane 1) or nuclear (lane 2) protein extract was 
carried out with 254 nm light at a distance of 2 cm for 15 min on ice 
in the presence of 2 mg/ml heparin and 200 ng/pl E. coii tRNA. RNase- 
digested reactions were run in non-reducing conditions in a 7.5% SDS- 
PAGE. The asterisk indicates the interface between the stacking and 
separating gels, and the bars indicate the migration of 200 kDa, 97 kDa 
and 69 kDa molecular weight standards. 
teins visualises them in autoradiography after SDS- 
PAGE. If Tl’ oligonucleotide was annealed to the probe 
before binding and irradiation in these assays, neither the 
whole 0.3 kb PA1 probe nor the 0.15 kb &PI-Hind probe 
cross-linked to the cytoplasmic proteins (not shown). 
One major radioactive band was seen when cytoplasmic 
protein extract was used with both of these probes with- 
out the annealed oligonucleotide. This protein migrated 
as a single 67 kDa polypeptide in SDS-PAGE [9], (seen 
also in Fig. 3B, lane 1). Experiments with nuclear extract 
from 3T3 cells and the PA1 probe demonstrated several 
proteins that had acquired label from the RNA probe. 
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One of them had a 67 kDa mobility equal to al-RBF,, 
in cytoplasmic extracts (Fig. 3B, lane 2). Similar results 
were obtained when human fibroblast nuclear and cyto- 
plasmic extracts were used, although in human cells, the 
pattern of other nuclear RNA-binding proteins was 
somewhat different (see below). Cytoplasmic extracts 
contained only one major PAl-binding protein corre- 
sponding to al -RBF,,, although in some reactions we 
have also seen a complex of over 200 kDa size in fibro- 
blasts (not shown). Thus, nuclear extracts contain a pro- 
tein that migrates in the electrophoresis like the cytoplas- 
mic al-RBF,, and binds to the same short segment of 
PA1 probe. 
Three methods were used to generate nuclear and cy- 
toplasmic extracts and, furthermore, Triton X-100 lysis 
was used for preparation of a cytoplasmic extract. In one 
of the methods swollen cells are lysed with passages 
through a 25-gauge needle and in the two other methods 
by dounce homogenisation. The latter methods differ in 
the conditions used for the centrifugation of the nuclei. 
All the extracts contained al-RBF,,. None of the other 
nuclear al (I) collagen mRNA-binding proteins were 
found in cytoplasmic or Triton extracts. Previously, dis- 
tribution of nuclear and cytoplasmic hnRNP proteins 
[18] and an AU-rich element binding protein [19] have 
been established by comparable extracts. We tested the 
extracts also for the distribution of the transcription fac- 
tor Spl. Binding of this protein to its double stranded 
consensus binding site oligonucleotide was seen when the 
nuclear extract was used but not when either the cyto- 
plasmic extracts or the Triton X-100 extract was used 
(not shown). 
It is most likely that al-RBF,, is present both in the 
nucleus and cytoplasm, whereas most of the nuclear 
RNA-binding proteins that recognise the 3’-UTR of 
al(I) collagen mRNA are not detectable in cytoplasmic 
extracts. Additional evidence for the identity of the nu- 
clear and cytoplasmic oil-RBF,, activities was obtained 
by peptide mapping. The proteins cross-linked to the 
&PI-Hind111 probe were digested by either V8 protease 
or CNBr and the peptide bound to RNA probe was 
visualised by autoradiography after SDS-PAGE. V8 
protease digestion of the protein-RNA complex resulted 
in a approximately 14 kDa peptide with both the cyto- 
plasmic and nuclear extracts, and the CNBr cleavage 
resulted in a peptide of about 40 kDa (not shown). 
These findings bear direct consequences to explaining 
roles of al-RBF,,. It is the major cytoplasmic protein 
that can be shown with the current methods to interact 
with the conserved 3’-UTR domain of al(I) collagen 
mRNA in fibroblasts. Furthermore, the binding activity 
is decreased when cells are treated with glucocorticoid 
hormones that decrease the stability of the al(I) collagen 
mRNA. The present results are also consistent with the 
hypothesis that al-RBF 67 binds to the already in the 
nucleus and is transported to the cytoplasm as the 
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Fig. 4. Diamide treatment abolishes reversibly the RNA-protein bind- 
ing activity. 3T3 nuclear extract was treated without (lane 1) or with 
(lanes 2 and 3) 5 mM diamide at room temperature, 2-mercaptoethanol 
(5% final) was added to reaction in lane 3 for additional 10 min. Binding 
reaction and electrophoresis were performed as described in Fig. 2. 
mRNP complex. Further experiments are needed to dis- 
sect, whether al-RBF,, participates mainly in the trans- 
port and targeting of mRNA or in the maintenance of 
its stability. 
A few RNA-binding proteins are known to shuttle 
between nucleus and cytoplasm. Recently, a tRNA bind- 
ing protein in HeLa nuclei was identified as the glycolytic 
enzyme glyceraldehyde-3-phosphate d hydrogenase and 
it was suggested that it functions in the nuclear export 
of tRNA [20]. In a similar way, several hnRNA binding 
proteins have been shown to actively shuttle between 
nucleus and cytoplasm and to bind mRNA in the cyto- 
plasm [18]. Proteins associated with RNA stability are 
also found in the nucleus. A 32 kDa polypeptide that 
recognises AU-rich domains of several short-lived 
mRNAs is found predominantly in the nucleus, although 
it is present in the cytoplasm, too [6]. Interestingly, one 
AU-rich element binding protein, AUBF has been 
shown to increase the export of AU-rich RNAs from 
nucleus to cytoplasm [7]. At the same time, AUBF puta- 
tively protects RNA from the nuclear matrix associated 
endoribonuclease [7]. Highly conserved 3’ UTRs and 
their cognate binding proteins may, indeed, have several 
simultaneous and unrelated tasks. For example, all de- 
scribed cases of mRNA localisation and subsequent non- 
uniform distribution in cytoplasm are mediated by cis- 
acting 3’-UTR sequences (discussed in [21]). 
We have also found that the binding mechanism of the 
cytoplasmic protein putatively involves free SH-groups 
in cysteine residues because N-ethylmaleimide treatment 
of the cytoplasmic extracts abolishes the binding. We 
wanted to verify, whether the redox change also regu- 
lates the binding of the nuclear counterpart of this bind- 
ing activity. To that purpose we used diamide, an oxidis- 
ing agent, the effect of which is, unlike that of NEM, 
reversible by reduction with 2-mercaptoethanol [22]. A 
lo-min incubation of the nuclear extract with 10 mM 
diamide effectively inhibited the subsequent complex for- 
mation of oil-RBF,, with the SspI-Hind111 RNA (Fig. 4), 
and the effect of diamide was reverted by application of 
2-mercaptoethanol for another 10 min after diamide but 
before addition of the probe (Fig. 4, lane 3). 
Redox regulation of transcription factors and RNA- 
binding proteins is a relatively newly found mechanism 
[22,23]. Binding of nuclear factors to an intronic AP-1 
site of al(I) collagen gene appears to be an important 
regulator of transcription [l&16]. We have previously 
shown that redox changes modulate the AP-1 binding at 
this site [16], and now present evidence for redox regula- 
tion of al(I) collagen RNA binding protein, &l-RBF,,, 
in nucleus. Thus, potential regulators of transcription 
and mRNA transport/stability could be inactivated or 
activated simultaneously. This might be a part of the 
mechanism that causes the well-documented parallel 
changes both in transcription and in mRNA stability of 
al(I) collagen gene (e.g. [1,2,3,17]). 
In the course of these studies we found that the 
amount and specificity of the nuclear RNA-binding pro- 
teins interacting with the PA1 probe varied in different 
cells. Many of these experiments were carried out with- 
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Fig. 5. Collagen RNA binding proteins are more specific in fibroblasts 
than in HeLa cells. (A) SDS-PAGE analysis of the RNA-protein com- 
plex formation in human fibroblasts. 10 pg fibroblast protein extract 
[l l] (lanes 1, 2 and 4 nuclear proteins; lane 3 cytoplasmic proteins, c) 
were cross-linked to 0.3 kb TaqI-Hind111 PA1 sense probe or to a probe 
transcribed from a PvuII digested pBluescript KS (Stratagene) plasmid 
(NS; lane 4) either in the presence (lanes 1 and 3) or absence (lanes 2 
and 4) of 1 mg/ml heparin. (B) UV cross-linking of HeLa nuclear 
extract proteins [I l] to PA1 sense probe. Lane (1) heparin omitted; (2) 
1 mg/ml heparin added; (3) pBluescript-derived non-specific probe. 
CNBr 
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Fig. 6 (A) Spl consensus oligonucleotide S-GCTCCAAGGGGCGGGGCAACCCAGGG was labelled with [y-“P]dATP, annealed to its comple- 
mentary strand and used in electrophoretic mobility shift assays. The binding reactions included 10 000 cpm of the probe 10 pg of the extracts and 
2pg of poly d[l.C]. Lane (1) probe alone, lane (2) nuclear extract, lane (3) cytoplasmic extract, lane (4) Triton extract. The arrow indicates the specific 
Spl complex (as evaluated by competition assays, mobility of the purified Spl protein and supershifts with specific antisera). The figure is a photocopy 
of an autoradiogram. (B) The nuclear and cytoplasmic extracts of 3T3 cells were UV cross-linked to the 0.15 SspI-Hind111 probe and cleaved with 
CNBr or V8 protease as described in section 2. CNBr-digested samples were evaporated to dryness before electrophoresis. V8 digestions giving 
identical results were performed with extracts described in the references [12 and 131. The CNBr cleavages were performed with the small-scaleextracts 
[13] only. 
out heparin to reveal also non-specific RNA-protein in- 
teractions. To characterise the additional proteins, we 
utilised HeLa cell nuclear extract and performed binding 
experiments with varying heparin concentrations and 
with different RNA-probes. As a control ‘nonsense’ 
probe, a PvuII digested pBluescript plasmid was used. 
Addition of heparin had only a minor effect on protein 
binding when fibroblast nuclear extract was used and 
complexes of 45, 67 (al-RBF,,) and 71 kDa were seen 
with or without heparin (Fig. 5A, lanes 1 and 2). HeLa 
nuclear extract contained, on the contrary, several pro- 
teins that reproducibly were recognised by the PA1 
probe: three proteins of 34-3645 and 51 kDa molecular 
weights were accompanied by a cluster of proteins in a 
size range between 65 and 103 kDa (~65, ~67, ~71, ~80, 
~87, ~103) (Fig. 5B, lane 1.). Heparin treatment effi- 
ciently inhibited the binding of some of the proteins leav- 
ing a doublet at about 67 kDa and single prominent 
bands of 45 and 51 kDa (Fig. 5B lane 2). It should be 
noted that in 3T3 nuclear extract the pattern of the com- 
plexes (Fig. 3A) was somewhat different, apart al- 
RBF,,, (~65, ~67, ~80) from that in either human cell 
lines. 
The use of the pBluescript control probe (NS) turned 
out to be very informative on the specificity of the nu- 
clear RNA-protein binding. At least five proteins of 
HeLa nuclear extract bound to this probe (Fig. 5B, lane 
3). These complexes had the same mobility as the heparin 
sensitive complexes of same extract probed with the PA1 
sequences indicating that the 34-36, 80 and 87 kDa pro- 
teins are non-specific RNA-binding proteins present in 
the HeLa but absent in the fibroblast nuclear extracts, 
The fibroblast extract contained detectable amounts of 
only the 32 kDa nonsense probe binding protein (Fig. 
5A, lane 4), further indicating the specificity of the colla- 
gen RNA-binding proteins present in these cells. These 
results further address that there are several specific and 
non-specific proteins in the nuclear extracts that can bind 
the highly conserved 3’-UTR of al(I) collagen, and only 
the one corresponding to alRBF,, is found also in cyto- 
plasmic extracts. It might also be that a more differenti- 
ated phenotype expresses aselect subset of RNA-binding 
proteins and the large amount of non-specific proteins 
present in the HeLa extract reflects the transformed state 
of the cell line. The 51 kDa protein was present only in 
the HeLa cells, but was not characterised in detail. This 
protein might be interesting in further experiments, be- 
cause it has been demonstrated that in HeLa cells, pro 
al(I) collagen expression is strongly down-regulated at 
the post-transcriptional level [24]. 
In conclusion, the conserved 3’-UTR common to both 
al(I) collagen mRNA species binds several nuclear pro- 
teins. One of them appears to be similar and perhaps 
identical to a previously described cytoplasmic RNA- 
binding protein, al-RBF,,, which might thus participate 
also in mRNA transport or localisation. The enhance- 
ment of binding activity via reduction of cysteine resi- 
dues further addresses al -RBF 67 as a candidate for post- 
transcriptional determinant of dl (I) collagen gene ex- 
pression. 
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